Transcriptomics

Dataset Information

0

Transient splicing inhibition causes persistent DNA damage and enhances chemotherapy vulnerability in homologous recombination proficient triple-negative breast cancer


ABSTRACT: Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer. Most TNBCs are initially sensitive to DNA damaging chemotherapy, a substantial fraction acquire resistance to treatments and progress to advanced stages associated with poor prognosis. We identify the spliceosome U2 small nuclear ribonucleoprotein (snRNP) complex as a modulator of chemotherapy efficacy in TNBC. Transient treatment with U2snRNP inhibitors induced a persistent DNA damage in TNBC cells and patient-derived organoids (PDOs), regardless of their homologous recombination proficiency. Transcriptome analyses revealed that U2snRNP inhibition causes a pervasive deregulation of genes involved in the DNA damage response (DDR), which relied on their genomic structure characterized by a high number of small exons. Importantly, a pulse of splicing inhibition was sufficient to elicit long-lasting repression of DDR proteins and to enhance the cytotoxic effect of platinum-based drugs and poly ADP-ribose polymerase inhibitors (PARPi) in multiple TNBC models. These findings identify the U2snRNP as an actionable target that can be exploited to enhance chemotherapy efficacy in TNBCs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE271749 | GEO | 2025/07/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-01-15 | E-GEOD-43502 | biostudies-arrayexpress
2025-06-25 | GSE276098 | GEO
2015-09-02 | E-GEOD-60964 | biostudies-arrayexpress
2016-01-07 | E-GEOD-63581 | biostudies-arrayexpress
2016-01-07 | E-GEOD-63284 | biostudies-arrayexpress
2016-01-07 | E-GEOD-63582 | biostudies-arrayexpress
2015-09-02 | GSE60964 | GEO
2021-07-07 | PXD021726 | Pride
2024-07-08 | GSE252382 | GEO
2024-07-08 | GSE251708 | GEO